Randall Bartlett, Senior Director of Canadian Economics at Desjardins, offers sharp insights on the looming economic challenges posed by Trump’s potential tariffs on Canada. The conversation dives into the implications for U.S.-Canada relations and touches on interest rate shifts in Canada. Also thrillingly explored is Aspect Biosystems, a B.C. startup innovating diabetes treatment with 3D printing technology, which could revolutionize how the disease is managed, moving beyond traditional insulin injections.